SOURCE: Pipex Pharmaceuticals, Inc.

August 15, 2007 08:00 ET

Pipex Pharmaceuticals to Present at Noble Financial Small Cap Conference

ANN ARBOR, MI--(Marketwire - August 15, 2007) - Pipex Pharmaceuticals, Inc. (AMEX: PP), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of neurologic and fibrotic diseases, announced that it will present at the Noble Financial, Two Double-0-Seven Small Cap Conference at the Charleston Place Hotel in Charleston, South Carolina on August 20th at 11:30 a.m. Eastern Daylight Time. Steve H. Kanzer, Chairman and Chief Executive Officer, will make the presentation.

A live webcast will be available from the conference and may be accessed through Noble's conference website at The webcast will also be archived on Pipex's website for 30 days.

About Pipex Pharmaceuticals, Inc.

Pipex Pharmaceuticals, Inc. ("Pipex") is a specialty pharmaceutical company that is developing proprietary, late-stage drug candidates for the treatment of neurologic and fibrotic diseases. Pipex's strategy is to exclusively in-license proprietary, clinical-stage drug candidates and complete the further clinical testing, manufacturing and regulatory requirements sufficient to seek marketing authorizations via the filing of New Drug Applications (NDAs) with the FDA in the U.S. and Marketing Application Authorizations (MAAs) with the European Medicines Evaluation Agency (EMEA). For further information, please visit,

About Noble Financial

Noble Financial is a privately-held, full-service capital markets firm driven by what is often overlooked by other firms -- uncovering the value embedded in the orphaned, undiscovered or misunderstood company. The company focuses on converting market inefficiencies into profit opportunities. Noble Financial supports emerging companies through strategic advice, investment banking, market-making, sales & trading, comprehensive equity research, and the development of institutional support. Noble Financial's equity conferences -- 2007 marks their third annual -- allow for a unique blend of professional and personal interaction among a diverse cross-section of executives. The company has operated for 23 years and has offices in Florida and New York City. For further information, please visit and for further information on the conference, please visit

Contact Information

  • For Further Information Contact:

    Steve H. Kanzer, CPA, Esq.
    Chairman and Chief Executive Officer
    (734) 332-7800

    Thomas Redington (Investor Relations)
    Redington Inc.